Explore the words cloud of the DISCOVER project. It provides you a very rough idea of what is the project "DISCOVER" about.
The following table provides information about the project.
Coordinator |
NATIONAL UNIVERSITY OF IRELAND GALWAY
Organization address contact info |
Coordinator Country | Ireland [IE] |
Total cost | 904˙500 € |
EC max contribution | 904˙500 € (100%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2017 |
Funding Scheme | MSCA-RISE |
Starting year | 2018 |
Duration (year-month-day) | from 2018-01-01 to 2021-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | NATIONAL UNIVERSITY OF IRELAND GALWAY | IE (Galway) | coordinator | 121˙500.00 |
2 | CELL STRESS DISCOVERIES LIMITED | IE (GALWAY) | participant | 207˙000.00 |
3 | ENIOS APPLICATIONS IDIOTIKI KEFALAIOUCHIKI ETAIREIA | EL (KALLITHEA) | participant | 189˙000.00 |
4 | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | FR (PARIS) | participant | 148˙500.00 |
5 | DOKUZ EYLUL UNIVERSITESI | TR (ALSANCAK IZMIR) | participant | 103˙500.00 |
6 | APOFAS BIOTECH | FR (RENNES) | participant | 67˙500.00 |
7 | UNIVERSITAET BERN | CH (BERN) | participant | 67˙500.00 |
8 | IZMIR BIYOTIP VE GENOM MERKEZI | TR (IZMIR) | participant | 0.00 |
During tumour development there is a bi-directional communication between cancer cells and immune cells; the process termed tumour immune editing. The impact is reciprocal, shaping both the visibility and susceptibility of the tumour to immune eradication as well as the ability of the immune effector cells to recognise and launch an immune response against tumour cells. Death ligand-death receptor signalling is a key mechanism to kill tumour cells during the early stages of tumour development (tumour immune surveillance). However, the role of this signalling pathway in evolved tumours is poorly understood. Recent pioneering results from DISCOVER consortium members highlighted non-canonical signal tranduction pathways mediated by death receptors, which regulates both tumour cell behaviour (motility, invasion) and effector immune cell function in the tumour microenvironment. The aim of the DISCOVER proposal is to bring a collaborative research network together to determine the role of death ligand-death receptor signalling in tumour - immune cell interactions. The DISCOVER programme will determine how non-canonical signal transduction pathways driven by death receptors control effector immnue cell functions and tumour cell behaviour. The outputs of the research will be used to develop informed therapeutic strategies to interfere with non-canonical death receptor signalling in order to re-activate anti-tumour immune attack and sensitise tumour cells to this attack. The DISCOVER proposal will integrate the research activity of seven beneficiary organisations from 5 European countries, including 3 companies and create a framework for knowledge and reagent exchange for early stage and experienced researchers. The consortium will bring together scientists from immunology and cancer cell biology and combines these with expertise in systems biology, drug discovery and pre-clinical drug development thus forging a consortium where scientific discoveries drive innovation.
DISCOVER Facebook &Twitter accounts | Websites, patent fillings, videos etc. | 2020-02-11 14:31:56 |
DISCOVER website | Websites, patent fillings, videos etc. | 2020-02-11 14:31:56 |
Take a look to the deliverables list in detail: detailed list of DISCOVER deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Ludmila Cardoso Alves
Michael D Berger
Thodoris Koutsandreas
Nick Kirschke
Christoph Lauer
Roman Spörri
Aristotelis Chatziioannou
Nadia Corazza
Philippe Krebs Nonâ€apoptotic TRAIL function modulates NK cell activity during viral infection published pages: pages 1-17, ISSN: 1469-221X, DOI: 10.15252/embr.201948789 |
EMBO reports e48789 | 2020-02-11 |
2019 |
Agathe Dubuisson, Cécile Favreau, Eric Fourmaux, Sabrina Lareure, Rafael Rodrigues-Saraiva, Catherine Pellat-Deceunynck, Said El Alaoui, Olivier Micheau Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization published pages: , ISSN: 2041-4889, DOI: 10.1038/s41419-019-1343-5 |
Cell Death & Disease 10/2 | 2020-02-11 |
2018 |
Olivier Micheau Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation published pages: 715, ISSN: 1422-0067, DOI: 10.3390/ijms19030715 |
International Journal of Molecular Sciences 19/3 | 2020-02-11 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DISCOVER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "DISCOVER" are provided by the European Opendata Portal: CORDIS opendata.